Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates
Description
The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B and hepatitis E viruses represented a breakthrough in vaccine development. However, for dengue and COVID-19, technical complications, such as an
